![Simrat Randhawa](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermögen: 427 680 $ am 31.07.2026
Simrat Randhawa is currently Executive VP, Head-Research & Development at Dianthus Therapeutics, Inc. since 2023.
Former positions include Senior Vice President-Clinical & Medical Affairs at Aurinia Pharmaceuticals, Inc. from 2019 to 2022, and Head-Medical Affairs at BioMarin Pharmaceutical, Inc. Education includes an MBA from The Trustees of Columbia University in The City of New York and a doctorate from Drexel University College of Medicine.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.06.2026 | 4.000 ( 0,01 % ) | 427 680 $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| DIANTHUS THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 11.09.2023 |
| Unternehmen | Position | Ende |
|---|---|---|
| AURINIA PHARMACEUTICALS INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2022 |
| BIOMARIN PHARMACEUTICAL INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Drexel University College of Medicine
 Drexel University College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aurinia Pharmaceuticals, Inc.
 Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
Dianthus Therapeutics, Inc.
 Dianthus Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for patients with autoimmune and inflammatory diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
